Search by Drug Name or NDC
NDC 63561-0174-05 Methocarbamol Tablets, USP, 750 mg 750 mg/1 Details
Methocarbamol Tablets, USP, 750 mg 750 mg/1
Methocarbamol Tablets, USP, 750 mg is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Granulation Technology, Inc.. The primary component is METHOCARBAMOL.
MedlinePlus Drug Summary
Methocarbamol is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Methocarbamol is in a class of medications called muscle relaxants. It works by slowing activity in the nervous system to allow the body to relax
Related Packages: 63561-0174-05Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Methocarbamol
Product Information
| NDC | 63561-0174 |
|---|---|
| Product ID | 63561-0174_0d956873-02ee-650b-e063-6294a90ae305 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Methocarbamol Tablets, USP, 750 mg |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Methocarbamol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 750 |
| Active Ingredient Units | mg/1 |
| Substance Name | METHOCARBAMOL |
| Labeler Name | Granulation Technology, Inc. |
| Pharmaceutical Class | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212623 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63561-0174-05 (63561017405)
| NDC Package Code | 63561-0174-5 |
|---|---|
| Billing NDC | 63561017405 |
| Package | 500 TABLET, FILM COATED in 1 BOTTLE (63561-0174-5) |
| Marketing Start Date | 2024-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |